Amylyx Pharmaceuticals, Inc.
AMLX
Hisse Senetlerindeki Sıralama
#4265
Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical... Amylyx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm, primarily focused on creating therapies for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. A key asset in its developmental pipeline is AMX0035, a proprietary dual UPR-Bax apoptosis inhibitor. This compound, which integrates sodium phenylbutyrate and taurursodiol, is under investigation for treating ALS, and its application is also being explored for other neurodegenerative diseases. The company was established in 2013 and is based in Cambridge, Massachusetts.
Hisse Fiyatı
$29.32
Son senkronizasyon: 2026-10-21
Piyasa Değeri
$3.68B
Değişim (1 gün)
1.91%
Değişim (1 yıl)
97.84%
Ülke
US
Ticaret Amylyx Pharmaceuticals, Inc. (AMLX)
Kategori
Healthcare
Amylyx Pharmaceuticals, Inc. (AMLX) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $27.68 - 2026-10-01
Gün sonu en düşük fiyat: $19.75 - 2022-01-01
Gün sonu en düşük fiyat: $19.75 - 2022-01-01
Amylyx Pharmaceuticals, Inc. için hisse fiyatı geçmişi: 2022 - 2026
Yıllık Hisse Fiyatı Performansı
| Yıl | Performans |
|---|---|
| 2026 (TTM) | 41.29% |
| 2025 | 192.53% |
| 2024 | -69.40% |
| 2023 | -60.37% |
| 2022 | 0.00% |
Benzer şirketler veya rakiplerin hisse fiyatı
| Şirket | Hisse fiyatı | Değişim 1yıl% | Ülke |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.77 | -3.82% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
